Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANAB
#1815
AnaptysBio, Inc. Common Stock
55.050
0
+1.79%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+1.79%
Monthly Change
+11.53%
6 month change
+56.39%
Year Change
+56.39%
Previous Close
54.080
0
Open
55.050
0
Bid
Ask
Low
55.050
0
High
55.146
0
Volume
74
Markets
US Stock Market
Healthcare
ANAB
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
FDA accepts Vanda’s imsidolimab application for rare skin disorder
AnaptysBio stock hits 52-week high at $57.73
These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks
AnaptysBio stock hits 52-week high at $52.56
Biotech Leader Eyes Spinoff Amid Massive Sales Surge
AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AnaptysBio stock: UBS reiterates Buy rating amid ongoing GSK litigation
Royalty Pharma and Teva’s $500 million IL-15 deal boosts AnaptysBio stock
Anaptysbio CEO Faga sells $638k in shares
Anaptysbio CFO Mulroy sells $112k in shares
Anaptysbio (ANAB) chief medical officer sells $163,191 in stock
Anaptysbio CLO Loumeau sells $98,809 in shares